1-9 of 9
Carl E. Allen
Close
Sort by
Journal Articles

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab

Clinical Trials & Observations
Shanmuganathan Chandrakasan, Michael B. Jordan, Ashley Baker, Edward M. Behrens, Deepika Bhatla, May Chien, Olive S. Eckstein, Michael M. Henry, Michelle L. Hermiston, Ashley P. Hinson, Jennifer W. Leiding, Abiola Oladapo, Sachit A. Patel, Priti Pednekar, Anish K. Ray, Blachy Dávila Saldaña, Susmita N. Sarangi, Kelly J. Walkovich, John D. Yee, Adi Zoref-Lorenz, Carl E. Allen
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2248–2258.
https://doi.org/10.1182/bloodadvances.2023012217
Published: 2024
Includes: Supplemental data
Journal Articles

Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study

Clinical Trials & Observations
Birte Wistinghausen, Keri Toner, Donald A. Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela Chansky, Gloria Pezzella, Lauren Saguilig, Robert J. Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L. Hermiston, Carl E. Allen, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1116–1127.
https://doi.org/10.1182/bloodadvances.2023010832
Published: 2024
Includes: Supplemental data
Journal Articles

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Ashley V. Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, James A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S. Kean, K. Scott Baker, Lauri M. Burroughs, Jeffrey R. Andolina, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Julie-An Talano, Kirk R. Schultz, Elizabeth O. Stenger, Howard Lin, Adi Zoref-Lorenz, Kenneth L. McClain, Michael B. Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3725–3734.
https://doi.org/10.1182/bloodadvances.2022009478
Published: 2023
Includes: Supplemental data
Journal Articles

Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF V600E

Clinical Trials & Observations
Paul Milne, Harshal Abhyankar, Brooks Scull, Preeti Singh, Rikhia Chakraborty, Carl E. Allen, Matthew Collin
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4901–4904.
https://doi.org/10.1182/bloodadvances.2022007519
Published: 2022
Includes: Supplemental data
Journal Articles

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

Howard Lin, Brooks P. Scull, Baruch R. Goldberg, Harshal A. Abhyankar, Olive E. Eckstein, Daniel J. Zinn, Joseph Lubega, Jennifer Agrusa, Nader El Mallawaney, Nitya Gulati, Lisa Forbes, Ivan Chinn, Rikhia Chakraborty, Jessica Velasquez, Jordana Goldman, Dalia Bashir, Fong Lam, Eyal Muscal, Michael. M. Henry, Jay N. Greenberg, Stephan Ladisch, Michelle L. Hermiston, Lauren K. Meyer, Michael Jeng, Ahmed Naqvi, Kenneth McClain, Trung Nguyen, Hector Wong, Tsz-Kwong Man, Michael B. Jordan, Carl E. Allen
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3457–3467.
https://doi.org/10.1182/bloodadvances.2021004287
Published: 2021
Includes: Supplemental data
Journal Articles

BRAF V 600E or mutant MAP2K1 human CD34 + cells establish Langerhans cell–like histiocytosis in immune-deficient mice

Anahita Rafiei, C. Matthias Wilk, Patrick M. Helbling, Renier Myburgh, Yasuyuki Saito, Eugenia Haralambieva, Davide Soldini, Rikhia Chakraborty, Miriam Merad, Carl E. Allen, Cesar Nombela-Arrieta, Markus G. Manz
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4912–4917.
https://doi.org/10.1182/bloodadvances.2020001926
Published: 2020
Includes: Supplemental data
Journal Articles

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Global Advances
Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany
Journal: Blood Advances
Blood Adv (2020) 4 (16): 4007–4019.
https://doi.org/10.1182/bloodadvances.2020002178
Published: 2020
Journal Articles

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Karen Phaik Har Lim, Paul Milne, Michael Poidinger, Kaibo Duan, Howard Lin, Naomi McGovern, Harshal Abhyankar, Daniel Zinn, Thomas M. Burke, Olive S. Eckstein, Rikhia Chakraborty, Amel Sengal, Brooks Scull, Evan Newell, Miriam Merad, Kenneth L. McClain, Tsz-Kwong Man, Florent Ginhoux, Matthew Collin, Carl E. Allen
Journal: Blood Advances
Blood Adv (2020) 4 (1): 87–99.
https://doi.org/10.1182/bloodadvances.2019000488
Published: 2020
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

Swati Naik, Caridad A. Martinez, Bilal Omer, Ghadir Sasa, Khaled Yassine, Carl E. Allen, Kala Kamdar, Robert Orth, Mengfen Wu, Kathryn Leung, Stephen Gottschalk, Malcolm K. Brenner, Helen E. Heslop, Robert A. Krance
Journal: Blood Advances
Blood Adv (2019) 3 (18): 2689–2695.
https://doi.org/10.1182/bloodadvances.2018026203
Published: 2019